No Data
No Data
No Data
No Data
No Data
Express News | Marizyme Inc - Qualigen Purchased Exclusive Negotiation Period Ending May 31 for Proposing Broader Strategic Relationship Between Two Companies
Moomoo 24/7Apr 16 07:02 ET
Express News | Marizyme Inc - Qualigen Will Help Support Commercial Launch in United States of Duragraft
Moomoo 24/7Apr 16 07:00 ET
Express News | Marizyme Enters Into Co-Development Agreement With Qualigen Therapeutics for the Commercialization of FDA-Cleared Duragraft™
Moomoo 24/7Apr 16 07:00 ET
Qualigen Therapeutics' Novel Direct Pan-RAS Inhibitors Presented at American Association of Cancer Research (AACR) 2024 Annual Meeting
Qualigen Therapeutics, Inc. (Nasdaq: QLGN) today announces a poster presentation on its preclinical Novel Direct Pan-RAS Inhibitors was presented at the American Association for Cancer Research (AACR) Annual Meeting 2024 held April 5 – 10 in San Diego, California.
GlobeNewswireApr 10 08:00 ET
Express News | Qualigen Therapeutics Highlights Poster Featuring Early Clinical Experience With QN-302 At American Association Of Cancer Research 2024 Annual Meeting
Moomoo 24/7Apr 9 09:34 ET
Qualigen Therapeutics Announces Poster Featuring Positive Early Clinical Experience With QN-302, a Novel First-in-Class G-Quadruplex Experimental Anti-Cancer Drug, at the American Association of Cancer Research (AACR) 2024 Annual Meeting
CARLSBAD, Calif., April 09, 2024 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. ("Qualigen" or the "Company," Nasdaq: QLGN) today announces that a poster featuring its early clinical experience wit
GlobeNewswireApr 9 08:00 ET
Jaguar8 : DCB?
TrytosaveabitOP Jaguar8: DCB = Dead Cat Bounce
TrytosaveabitOP Jaguar8: Colloquial term used for a ticker that hits bottom and then gets a price increase for really no apparent reason except that it hit the bottom. Hope this helps a bit?
Jaguar8 TrytosaveabitOP: Got it!
No Data
No Data